Funding for this research was provided by:
Key scientific research projects of Institutions in Henan province, China (18A320014)
Received: 2 September 2019
Accepted: 6 June 2020
First Online: 15 June 2020
Ethics approval and consent to participate
: This study involving human participants and human cell lines DU145, LNcap, PC3 and 293 T was approved by the ethics committee of The First Affiliated Hospital of Zhengzhou University. The audit number of ethics committee was 2019-KY-185. Written consent was obtained from all human participants. Research was carried out according to the principles expressed in the Declaration of Helsinki.
: Not applicable.
: No conflict of interest exits in the submission of this manuscript, and the manuscript has been approved by all authors for publication.